The influence of fetal hemoglobin on clinical and hematological variables of children and adolescents with sickle cell anemia in Basra, Southern Iraq

Iranian Journal of Blood and Cancer

Volumn 7, Issue 4, 2015, Pages 179-183

  Badr, A K ^a   Hassan, Meaad K ^b  

^a Basra Medical College ^*

^b UNIVERSITY OF BASRAH   (Iraq)

Author keywords

Clinical severity; Complications; Fetal hemoglobin; Sickle cell anemia

Indexed keywords

HEMOGLOBIN F;

ACUTE CHEST SYNDROME; ADOLESCENT; ARTICLE; BLOOD CELL COUNT; BLOOD TRANSFUSION; BODY MASS; CHILD; DISEASE SEVERITY; FEMALE; GALLSTONE; HEART FAILURE; HEPATOMEGALY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HOSPITALIZATION; HUMAN; IRAQ; JAUNDICE; MALE; MEAN CORPUSCULAR HEMOGLOBIN; MEAN CORPUSCULAR VOLUME; PAIN; PALLOR; SCHOOL CHILD; SICKLE CELL ANEMIA; SPLENOMEGALY;

EID: 84944731201     PISSN: None     EISSN: 20084595     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Hassan MK, Taha JY, Al-Naama LM, Widad NM, Jasim SN. Frequency of hemoglobinopathies and glucose 6 phosphate dehydrogenase in Basrah. East Med Health J 2003; 9(1&2):45-54.
2. th ED. Philadelphia USA 2009: 1039-1067.
3. Goldberg MA, Husson MA, Bunn HF. Participation of Hemoglobins A and F in polymerization of sickle hemoglobin. J Biol Chem 2005; 252(10): 3414-3421.
4. Meier ER, Byrnes C, Weissman M, Noel P, Luban NLC, Miller JL. Expression patterns of fetal hemoglobin in sickle cell erythrocytes are both patient- and treatment-specific during childhood. Pediatr Blood Cancer 2011; 56(1): 103-109. doi:10.1002/pbc.22643.
5. th ED. Elsevier Burlington USA, 2005:157-179.
6. th ED. Blackwell Publishing Malden, Massachusetts, USA 2005:104-118.
7. Enosolease ME, Ejele OA, Awode OA. The influence of fetal hemoglobin on the frequency of vaso-occlusive crisis in sickle cell anemia. Niger postgraduate J 2005; 28(2):102-105.
8. Akinsheye I, Alsultan A, Solovieff N, Ngo D, Baldwin CT, Sebastiani P, et al. Fetal hemoglobin in sickle cell anemia. Blood 2011; 118(1):19-27.
9. Mpalampa L, Ndugwa CM, Ddungu H, Idro R. Foetal haemoglobin and disease severity in sickle cell anaemia patients in Kampala, Uganda. BMC Blood Disorders 2012, 12:11, http://www.biomedcentral. com/1471-2326/12/11
10. El-Hazmi MAF. Clinical and haematological diversity of sickle cell disease in Saudi Children. J Trop Pediatr 1992, 38:106-112.
11. Diop S, Thiam D, Cisse M, Toure-Fall AO, Fall K, Diakhate L. New results in clinical severity of homozygous sickle cell anemia in Dakar, Senegal. Hematol Cell Ther 1999, 41:2217-2221.
12. Ogedegbe HO. Sickle Cell Disease: An Overview. Laboratory medicine 2002; 33:515-542.
13. Coleman E, Inusa B. Sickle Cell Anemia: Targeting the Role of Fetal Hemoglobin in Therapy. Clinical Pediatrics 2007; 46(23) 1-6.
14. Frei-Jones MJ, Field JJ, DeBaun MR. Risk factors for hospital readmission within 30-days: A New quality measure for children with sickle cell disease. Pediatr Blood Cancer 2009; 52(4): 481- 485.
15. Omoti CE. Hematological values in sickle cell anaemia in steady state and during vaso-occlusive crisis in Benin City, Nigeria. Annals of African Medicine 2005; 4(2):62-67.
16. th ED. Philadelphia. WB Saunders Co.2007:232-242.
17. Al Gazali L, Hammy H, Al-Arrayad S. Genetic disorders in the Arab World. BMJ 2006; 333: 831- 834.
18. Chopra R, Al-Mulhim AR, Al-Baharani AT. Fibrocongestive splenomegaly in Sickle Cell Disease: A Distinct Clinicopathological Entity in the Eastern Province of Saudi Arabia. Am J of Hematology 2005; 79:180-186.
19. El-Kalla S, Baysal E. Genotype-phenotype correlation of sickle cell disease in the United Arab Emirates. Pediatr Hematol Oncol 1998; 15(3):237-242.
20. Jain D, Bagul AS, Shah M, Sarathi V. Morbidity pattern in hospitalized under five children with sickle cell disease. Indian J Med Res 2013; 138(3):317-321.
21. Darbari DS, Onyekwere O, Nouraie M, Minniti CP, Luchtman-Jones L, Rana S, et al. Markers of severe vaso-occlusive painful episode frequency in children and adolescents with sickle cell anemia. J Pediatr 2012; 160(2): 286-290. doi:10.1016/j. jpeds.2011.07.018.
22. Bailey K, Morris JS, Thomas P, Serjeant GR. Fetal hemoglobin and early manifestations of homozygous sickle cell disease. Arch Dis Child 1992; 67: 517-520.
23. Russo-Mancuso G, Romeo MA, Guardabasso V, Schiliro G. Survey of sickle cell disease in Italy. Haematologica 1998; 83(10):875-881.
24. Inati A, Jradi O, Tarabay H, Moallem H, Rachkidi Y, El Accaoui R, et al. Sickle Cell Disease in Lebanon. Int J Lab Hem 2007; 29, 399-408.
25. Parmar D, Likhar KS. Prevalence of splenomegaly in Sickle cell anemia patients in relation to Hemoglobin F. IJRRMS 2013; 3(3): 18-20.
26. Steinberg MH. Predicting clinical severity in sickle cell anemia. Br J Hematol 2005; 129: 465-481.
27. Kato GJ, Gladwin MT, Steinberg MH. Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes. Blood Rev 2007; 21(1):37-47.
28. Singhal A, Morris J, Thomas P, Dover G, Higgs D, Serjeant G. Factors affecting prepubertal growth in homozygous sickle cell disease. Arch Dis Child 1996; 74: 502-506.
29. Steinberg MH, Chui DH, Dover GJ, Sebastiani P, Alsultan A. Fetal hemoglobin in sickle cell anemia: a glass half full? Blood 2014; 123(4):481-485.
30. Das S. A study to understand the relation between fetal haemoglobin, the hematological parameters and Xmn i gene polymorphism. Indian Journal of Medicine and Healthcare 2012; 1(9):206-210.
31. Tshilolo L, Summa V, Gregorj C, Kinsiama C, Bazeboso JA, Avvisati G, et al. Foetal Haemoglobin, Erythrocytes Containing Foetal Haemoglobin, and Hematological Features in Congolese Patients with Sickle Cell Anaemia. Hindawi Publishing Corporation Anemia. Volume 2012, Article ID 105349, doi:10.1155/2012/105349.